R-Pharm to invest 100 million euros in building a Turkish production plant

R-Pharm, one of Russia's leading pharmaceutical producers, has officially announced the initiation of production of its drugs in Turkey and the possibility of establishment of its own manufacturing facility in the country.

According to Vasily Ignatiev, chief executive of R-Pharm, the company has recently established its subsidiary in Turkey, which will specialize in the registration, promoting and selling of its drugs in the country. The company expects that its Turkish branch will help it to start export of its drugs to the Middle East and African countries.

Mr Ignatiev added that, during the second stage, the company will establish its own biotechnology production in the country. Total investment in the project is estimated at 100 million euros ($128 million).